{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:07Z","timestamp":1790646967379,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00277856"],"award-info":[{"award-number":["RS-2023-00277856"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["(RS-2025-24535069"],"award-info":[{"award-number":["(RS-2025-24535069"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:bold>\n                        <jats:italic>BACKGROUND<\/jats:italic>\n                      <\/jats:bold>\n                      :\n                    <\/jats:title>\n                    <jats:p>Bone marrow\u2013derived MSCs (BMMSCs) are limited by availability, donor variability, and age-related decline, highlighting the need for alternative MSC sources. Induced pluripotent stem cells (iPSCs) offer a scalable solution. This study introduces a novel three-dimensional culture platform based on fibronectin (FN)-coated microparticles to efficiently derive and expand human iPSC-derived MSCs (iMSCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:bold>\n                        <jats:italic>METHODS<\/jats:italic>\n                      <\/jats:bold>\n                      :\n                    <\/jats:title>\n                    <jats:p>\n                      The system utilizes FN-coated non-porous (CytoDex) and porous (CytoPore) microparticles. FN coating efficacy on microparticle was confirmed using Rhodamine-labeled FN and confocal microscope. Base on various molecular cell biological experiment, the utilization of FN-coated CytoDex and CytoPore leverages an expanded surface area to improve iMSCs isolation. The characteristics and cell behaviors of iMSCs generated from FN-coated CytoDex and CytoPore was evaluated by immunophenotype analysis, cell proliferation, and senescence related assays.\n                      <jats:italic>In vivo<\/jats:italic>\n                      tissue regeneration was evaluated by microcomputed tomography and histopathological analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:bold>\n                        <jats:italic>RESULTS<\/jats:italic>\n                      <\/jats:bold>\n                      :\n                    <\/jats:title>\n                    <jats:p>\n                      The porous microparticle CytoPore significantly enhanced FN coating efficiency, cell attachment, and proliferation compared to CytoDex. FN-coated CytoPore enabled the selective isolation of a high-purity MSC population from spontaneously differentiated iPSCs (SD-iPSCs) by day 7, confirmed by distinct morphology and mesodermal marker expression. The resulting iMSCs exhibited immunophenotypic characteristics comparable to adult MSCs, along with superior proliferative capacity, extended telomere length, and minimal senescence over 10 passages, in contrast to BMMSCs. Furthermore, iMSCs demonstrated effective\n                      <jats:italic>in vivo<\/jats:italic>\n                      tissue regeneration in an osteochondral defect model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:bold>\n                        <jats:italic>CONCLUSION<\/jats:italic>\n                      <\/jats:bold>\n                      :\n                    <\/jats:title>\n                    <jats:p>This novel FN-coated microparticle-based 3D culture platform enables efficient, large-scale production of high-quality iMSCs and holds strong potential for clinical applications in stem cell therapeutics and regenerative medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13770-026-00822-4","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:53:10Z","timestamp":1787388790000},"page":"1027-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs"],"prefix":"10.1007","volume":"23","author":[{"given":"Jae Hyeok","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Sun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Seob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-8854","authenticated-orcid":false,"given":"Byung-Hyun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"822_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-025-11011-6","volume":"22","author":"X Zhao","year":"2026","unstructured":"Zhao X, Ming X, Wu J, Zhu X, Xiao Y. Mesenchymal stromal cells: bridging the gaps in hematologic disease therapy. Stem Cell Rev Rep. 2026;22:434\u201388.","journal-title":"Stem Cell Rev Rep"},{"key":"822_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.stem.2021.09.006","volume":"28","author":"M Krampera","year":"2021","unstructured":"Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell. 2021;28:1708\u201325.","journal-title":"Cell Stem Cell"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L, et al. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025;10:262.","journal-title":"Signal Transduct Target Ther"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"822_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13287-021-02694-y","volume":"13","author":"LT Nguyen","year":"2022","unstructured":"Nguyen LT, Tran NT, Than UTT, Nguyen MQ, Tran AM, Do PTX, et al. Optimization of human umbilical cord blood-derived mesenchymal stem cell isolation and culture methods in serum- and xeno-free conditions. Stem Cell Res Ther. 2022;13:15.","journal-title":"Stem Cell Res Ther"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","volume":"22","author":"MA Baxter","year":"2004","unstructured":"Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675\u201382.","journal-title":"Stem Cells"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","volume":"129","author":"A Stolzing","year":"2008","unstructured":"Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163\u201373.","journal-title":"Mech Ageing Dev"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1089\/ten.tea.2010.0085","volume":"16","author":"BL Larson","year":"2010","unstructured":"Larson BL, Ylostalo J, Lee RH, Gregory C, Prockop DJ. Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A. 2010;16:3385\u201394.","journal-title":"Tissue Eng Part A"},{"key":"822_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1073\/pnas.1423008112","volume":"112","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Gregory CA, Lee RH, Reger RL, Qin L, Hai B, et al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2015;112:530\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41536-024-00382-y","volume":"10","author":"M Hodgson-Garms","year":"2025","unstructured":"Hodgson-Garms M, Moore MJ, Martino MM, Kelly K, Frith JE. Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing. NPJ Regen Med. 2025;10:7.","journal-title":"NPJ Regen Med"},{"key":"822_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","volume":"16","author":"G Liu","year":"2020","unstructured":"Liu G, David BT, Trawczynski M, Fessler RG. Advances in pluripotent stem cells: history, mechanisms, technologies, and applications. Stem Cell Rev Rep. 2020;16:3\u201332.","journal-title":"Stem Cell Rev Rep"},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13287-015-0137-7","volume":"6","author":"R Kang","year":"2015","unstructured":"Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144.","journal-title":"Stem Cell Res Ther"},{"key":"822_CR13","first-page":"682","volume":"85","author":"T Aoi","year":"2023","unstructured":"Aoi T, Tanaka A, Furuhashi K, Ikeya M, Shimizu A, Arioka Y, et al. <Editors\u2019 Choice> Mesenchymal stem\/stromal cells generated from induced pluripotent stem cells are highly resistant to senescence. Nagoya J Med Sci. 2023;85:682\u201390.","journal-title":"Nagoya J Med Sci"},{"key":"822_CR14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/sctm.21-0151","volume":"10","author":"RE Rogers","year":"2021","unstructured":"Rogers RE, Haskell A, White BP, Dalal S, Lopez M, Tahan D, et al. A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers. Stem Cells Transl Med. 2021;10:1650\u201365.","journal-title":"Stem Cells Transl Med"},{"key":"822_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/bit.25187","volume":"111","author":"F Dos Santos","year":"2014","unstructured":"Dos Santos F, Campbell A, Fernandes-Platzgummer A, Andrade PZ, Gimble JM, Wen Y, et al. A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem\/stromal cells. Biotechnol Bioeng. 2014;111:1116\u201327.","journal-title":"Biotechnol Bioeng"},{"key":"822_CR16","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/bit.24425","volume":"109","author":"NE Timmins","year":"2012","unstructured":"Timmins NE, Kiel M, Gunther M, Heazlewood C, Doran MR, Brooke G, et al. Closed system isolation and scalable expansion of human placental mesenchymal stem cells. Biotechnol Bioeng. 2012;109:1817\u201326.","journal-title":"Biotechnol Bioeng"},{"key":"822_CR17","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10529-013-1211-9","volume":"35","author":"QA Rafiq","year":"2013","unstructured":"Rafiq QA, Brosnan KM, Coopman K, Nienow AW, Hewitt CJ. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett. 2013;35:1233\u201345.","journal-title":"Biotechnol Lett"},{"key":"822_CR18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jcyt.2024.07.003","volume":"26","author":"RP Soder","year":"2024","unstructured":"Soder RP, Dudley NR, Dawn B. Microcarrier-based clinical-grade manufacturing of therapeutic Wharton\u2019s jelly mesenchymal stromal cells. Cytotherapy. 2024;26:1556\u201365.","journal-title":"Cytotherapy"},{"key":"822_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13287-023-03514-1","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Ouyang L, Chen W, Cao Y, Zhang L. Efficient expansion and delayed senescence of hUC-MSCs by microcarrier-bioreactor system. Stem Cell Res Ther. 2023;14:284.","journal-title":"Stem Cell Res Ther"},{"key":"822_CR20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.biotechadv.2013.03.006","volume":"31","author":"AK Chen","year":"2013","unstructured":"Chen AK, Reuveny S, Oh SK. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv. 2013;31:1032\u201346.","journal-title":"Biotechnol Adv"},{"key":"822_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jot.2015.02.003","volume":"3","author":"B Li","year":"2015","unstructured":"Li B, Wang X, Wang Y, Gou W, Yuan X, Peng J, et al. Past, present, and future of microcarrier-based tissue engineering. J Orthop Translat. 2015;3:51\u20137.","journal-title":"J Orthop Translat"},{"key":"822_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/ten.tec.2020.0039","volume":"26","author":"X Yan","year":"2020","unstructured":"Yan X, Zhang K, Yang Y, Deng D, Lyu C, Xu H, et al. Dispersible and dissolvable porous microcarrier tablets enable efficient large-scale human mesenchymal stem cell expansion. Tissue Eng Part C Methods. 2020;26:263\u201375.","journal-title":"Tissue Eng Part C Methods"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13578-020-00438-8","volume":"10","author":"B Koh","year":"2020","unstructured":"Koh B, Sulaiman N, Fauzi MB, Law JX, Ng MH, Idrus RBH, et al. Three dimensional microcarrier system in mesenchymal stem cell culture: a systematic review. Cell Biosci. 2020;10:75.","journal-title":"Cell Biosci"},{"key":"822_CR24","doi-asserted-by":"publisher","first-page":"2001365","DOI":"10.1002\/advs.202001365","volume":"7","author":"BH Cha","year":"2020","unstructured":"Cha BH, Kim JS, Bello A, Lee GH, Kim DH, Kim BJ, et al. Efficient isolation and enrichment of mesenchymal stem cells from human embryonic stem cells by utilizing the interaction between integrin alpha5beta1 and fibronectin. Adv Sci (Weinh). 2020;7:2001365.","journal-title":"Adv Sci (Weinh)"},{"key":"822_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1474-9726.2008.00377.x","volume":"7","author":"S Zhou","year":"2008","unstructured":"Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335\u201343.","journal-title":"Aging Cell"},{"key":"822_CR26","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jcyt.2024.03.486","volume":"26","author":"A Trivedi","year":"2024","unstructured":"Trivedi A, Lin M, Miyazawa B, Nair A, Vivona L, Fang X, et al. Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells: implications for clinical applications. Cytotherapy. 2024;26:1062\u201375.","journal-title":"Cytotherapy"},{"key":"822_CR27","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1089\/ten.tea.2008.0351","volume":"15","author":"NL Boyd","year":"2009","unstructured":"Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A. 2009;15:1897\u2013907.","journal-title":"Tissue Eng Part A"},{"key":"822_CR28","doi-asserted-by":"publisher","first-page":"1792744","DOI":"10.3389\/fcell.2026.1792744","volume":"14","author":"P Gangadaran","year":"2026","unstructured":"Gangadaran P, Rajendran RL, Muthu S, Ahn BC. Decoding induced mesenchymal stem cells functionality: why differentiation protocols matter. Front Cell Dev Biol. 2026;14:1792744.","journal-title":"Front Cell Dev Biol"},{"key":"822_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","volume":"13","author":"SE Haynesworth","year":"1992","unstructured":"Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13:81\u20138.","journal-title":"Bone"},{"key":"822_CR30","doi-asserted-by":"publisher","first-page":"e33225","DOI":"10.1371\/journal.pone.0033225","volume":"7","author":"Y Liu","year":"2012","unstructured":"Liu Y, Goldberg AJ, Dennis JE, Gronowicz GA, Kuhn LT. One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS ONE. 2012;7:e33225.","journal-title":"PLoS ONE"},{"key":"822_CR31","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.mtbio.2020.100054","volume":"6","author":"Y Naka","year":"2020","unstructured":"Naka Y, Kitano S, Irie S, Matsusaki M. Wholly vascularized millimeter-sized engineered tissues by cell-sized microscaffolds. Mater Today Bio. 2020;6:100054.","journal-title":"Mater Today Bio"},{"key":"822_CR32","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.actbio.2010.11.010","volume":"7","author":"G Dubey","year":"2011","unstructured":"Dubey G, Mequanint K. Conjugation of fibronectin onto three-dimensional porous scaffolds for vascular tissue engineering applications. Acta Biomater. 2011;7:1114\u201325.","journal-title":"Acta Biomater"},{"key":"822_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jbiotec.2016.08.007","volume":"236","author":"AM de Soure","year":"2016","unstructured":"de Soure AM, Fernandes-Platzgummer A, da Silva CL, Cabral JM. Scalable microcarrier-based manufacturing of mesenchymal stem\/stromal cells. J Biotechnol. 2016;236:88\u2013109.","journal-title":"J Biotechnol"},{"key":"822_CR34","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fbioe.2020.00640","volume":"8","author":"AC Tsai","year":"2020","unstructured":"Tsai AC, Jeske R, Chen X, Yuan X, Li Y. Influence of microenvironment on mesenchymal stem cell therapeutic potency: from planar culture to microcarriers. Front Bioeng Biotechnol. 2020;8:640.","journal-title":"Front Bioeng Biotechnol"},{"key":"822_CR35","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1016\/j.biomaterials.2009.06.056","volume":"30","author":"IF Amaral","year":"2009","unstructured":"Amaral IF, Unger RE, Fuchs S, Mendonca AM, Sousa SR, Barbosa MA, et al. Fibronectin-mediated endothelialisation of chitosan porous matrices. Biomaterials. 2009;30:5465\u201375.","journal-title":"Biomaterials"},{"key":"822_CR36","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jcyt.2016.06.016","volume":"18","author":"A Shekaran","year":"2016","unstructured":"Shekaran A, Lam A, Sim E, Jialing L, Jian L, Wen JT, et al. Biodegradable ECM-coated PCL microcarriers support scalable human early MSC expansion and in vivo bone formation. Cytotherapy. 2016;18:1332\u201344.","journal-title":"Cytotherapy"},{"key":"822_CR37","doi-asserted-by":"publisher","first-page":"1282860","DOI":"10.3389\/fcell.2023.1282860","volume":"11","author":"T Tertel","year":"2023","unstructured":"Tertel T, Dittrich R, Arsene P, Jensen A, Giebel B. EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro. Front Cell Dev Biol. 2023;11:1282860.","journal-title":"Front Cell Dev Biol"},{"key":"822_CR38","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.mtbio.2023.100662","volume":"20","author":"T Gao","year":"2023","unstructured":"Gao T, Zhao X, Hao J, Tian Y, Ma H, Liu W, et al. A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells. Mater Today Bio. 2023;20:100662.","journal-title":"Mater Today Bio"},{"key":"822_CR39","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1089\/scd.2013.0554","volume":"23","author":"EA Kimbrel","year":"2014","unstructured":"Kimbrel EA, Kouris NA, Yavanian GJ, Chu J, Qin Y, Chan A, et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev. 2014;23:1611\u201324.","journal-title":"Stem Cells Dev"},{"key":"822_CR40","doi-asserted-by":"crossref","unstructured":"Lee HR, Kim S, Shin S, Jeong SY, Lee DW, Lim SU, et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs. Int J Mol Sci. 2023;24:881.","DOI":"10.3390\/ijms24010881"},{"key":"822_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.109.898312","volume":"121","author":"Q Lian","year":"2010","unstructured":"Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121:1113\u201323.","journal-title":"Circulation"},{"key":"822_CR42","doi-asserted-by":"publisher","first-page":"e00623","DOI":"10.1002\/adbi.202500623","volume":"10","author":"A Sanap","year":"2026","unstructured":"Sanap A, Ashok A, Raundal K, Kheur S, Badhe R, Bhonde R. iMSCs vs MSCs: comparative features and therapeutic potential in wound healing. Adv Biol Weinh. 2026;10:e00623.","journal-title":"Adv Biol Weinh"},{"key":"822_CR43","doi-asserted-by":"crossref","unstructured":"Choudhery MS, Arif T, Mahmood R, Mushtaq A, Niaz A, Hassan Z, et al. Induced mesenchymal stem cells: an emerging source for regenerative medicine applications. J Clin Med. 2025;14:2053.","DOI":"10.3390\/jcm14062053"},{"key":"822_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13287-019-1209-x","volume":"10","author":"LS Spitzhorn","year":"2019","unstructured":"Spitzhorn LS, Megges M, Wruck W, Rahman MS, Otte J, Degistirici O, et al. Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Res Ther. 2019;10:100.","journal-title":"Stem Cell Res Ther"},{"key":"822_CR45","doi-asserted-by":"crossref","unstructured":"Dias IX, Cordeiro A, Guimaraes JAM, Silva KR. Potential and limitations of induced pluripotent stem cells-derived mesenchymal stem cells in musculoskeletal disorders treatment. Biomolecules. 2023;13:1342.","DOI":"10.3390\/biom13091342"},{"key":"822_CR46","doi-asserted-by":"publisher","first-page":"1005926","DOI":"10.3389\/fcell.2022.1005926","volume":"10","author":"K Thanaskody","year":"2022","unstructured":"Thanaskody K, Jusop AS, Tye GJ, Wan Kamarul Zaman WS, Dass SA, Nordin F. MSCs vs. iPSCs: potential in therapeutic applications. Front Cell Dev Biol. 2022;10:1005926.","journal-title":"Front Cell Dev Biol"},{"key":"822_CR47","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1242\/jcs.076935","volume":"124","author":"J Veevers-Lowe","year":"2011","unstructured":"Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM. Mesenchymal stem cell migration is regulated by fibronectin through alpha5beta1-integrin-mediated activation of PDGFR-beta and potentiation of growth factor signals. J Cell Sci. 2011;124:1288\u2013300.","journal-title":"J Cell Sci"},{"key":"822_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2334\/josnusd.46.207","volume":"46","author":"N Ogura","year":"2004","unstructured":"Ogura N, Kawada M, Chang WJ, Zhang Q, Lee SY, Kondoh T, et al. Differentiation of the human mesenchymal stem cells derived from bone marrow and enhancement of cell attachment by fibronectin. J Oral Sci. 2004;46:207\u201313.","journal-title":"J Oral Sci"},{"key":"822_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41419-019-1498-0","volume":"10","author":"L Devito","year":"2019","unstructured":"Devito L, Klontzas ME, Cvoro A, Galleu A, Simon M, Hobbs C, et al. Comparison of human isogeneic Wharton\u2019s jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation. Cell Death Dis. 2019;10:277.","journal-title":"Cell Death Dis"},{"key":"822_CR50","doi-asserted-by":"publisher","first-page":"115324","DOI":"10.1016\/j.colsurfb.2025.115324","volume":"259","author":"L Wang","year":"2026","unstructured":"Wang L, Li Q, Li Y, Chen L, Yang J, Wang P, et al. A three-stage differentiation method for generating induced mesenchymal stem cells from human pluripotent stem cells via gelatin-based screening. Colloids Surf B Biointerfaces. 2026;259:115324.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"822_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/jor.26040","volume":"43","author":"S Chihab","year":"2025","unstructured":"Chihab S, Khan NM, Eng T, Doan T, Kaiser JM, Drissi H. Kartogenin enhances chondrogenic differentiation of iPSC derived MSCs (iMSCs) and improves outcomes in an osteochondral defect model in male rats. J Orthop Res. 2025;43:870\u201380.","journal-title":"J Orthop Res"},{"key":"822_CR52","doi-asserted-by":"publisher","first-page":"e10629","DOI":"10.1002\/btm2.10629","volume":"9","author":"J Kim","year":"2024","unstructured":"Kim J, Kim JS, Kim D, Bello AB, Kim BJ, Cha BH, et al. Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration. Bioeng Transl Med. 2024;9:e10629.","journal-title":"Bioeng Transl Med"},{"key":"822_CR53","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1038\/srep02243","volume":"3","author":"L Zou","year":"2013","unstructured":"Zou L, Luo Y, Chen M, Wang G, Ding M, Petersen CC, et al. A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep. 2013;3:2243.","journal-title":"Sci Rep"},{"key":"822_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13287-024-03847-5","volume":"15","author":"K Gupta","year":"2024","unstructured":"Gupta K, Perkerson RB 3rd, Parsons TM, Angom R, Amerna D, Burgess JD, et al. Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage. Stem Cell Res Ther. 2024;15:230.","journal-title":"Stem Cell Res Ther"},{"key":"822_CR55","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7150\/ijbs.14809","volume":"12","author":"X Qi","year":"2016","unstructured":"Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci. 2016;12:836\u201349.","journal-title":"Int J Biol Sci"},{"key":"822_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41413-019-0069-4","volume":"7","author":"P Jungbluth","year":"2019","unstructured":"Jungbluth P, Spitzhorn LS, Grassmann J, Tanner S, Latz D, Rahman MS, et al. Human iPSC-derived iMSCs improve bone regeneration in mini-pigs. Bone Res. 2019;7:32.","journal-title":"Bone Res"},{"key":"822_CR57","doi-asserted-by":"publisher","first-page":"117649","DOI":"10.1016\/j.biopha.2024.117649","volume":"181","author":"G Cheng","year":"2024","unstructured":"Cheng G, Wang X, Zhang F, Wang K, Li Y, Guo T, et al. Reparative homing of bone mesenchymal stem cells induced by iMSCs via the SDF-1\/CXCR4 axis for articular cartilage defect restoration. Biomed Pharmacother. 2024;181:117649.","journal-title":"Biomed Pharmacother"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13770-026-00822-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-026-00822-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:32Z","timestamp":1790643872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13770-026-00822-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s13770-026-00822-4","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal studies were performed after receiving approval of the Institutional Animal Care and Use Committee (IACUC) in Dongguk University (IACUC approval No. IACUC-2024\u2013036-1).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}